News

PathPresenter and Primaa Partner to Advance AI in Dermatopathology

AVANT BIO portfolio company PathPresenter announced a partnership with Primaa to integrate Cleo Skin — the world’s first AI-based tool for dermatopathology — into its clinical image management system.

The collaboration combines Primaa’s advanced AI model with PathPresenter’s FDA 510(k)- and CE-IVDR-cleared digital pathology platform, giving pathologists worldwide access to AI-assisted classification for melanoma, squamous cell carcinoma, and basal cell carcinoma.

Why it matters:

  • AI for clinical practice: Empowers faster, more precise diagnoses from digitized slides.
  • Scalable interoperability: Expands access to validated AI within existing digital workflows.
  • Educational and clinical validation: Live demos at ASDP 2025 and inclusion in CAP’s interactive AI Studio.

Read the full announcement